00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Trump's proposed tariffs on imported generic drugs would likely raise medicine prices for
00:06U.S. patients.
00:08Dr. Reddy's Laboratory's CEO, Erez Israeli, told CNBC that generic drug makers operate
00:14on thin margins and cannot absorb tariffs of 100 percent to 200 percent, meaning prices
00:19would likely rise by roughly the amount of the tariff.
00:22Trump announced imported generic drugs will face no tariffs for two years starting August
00:271, followed by a 100 percent tariff in August 2028 and a 200 percent tariff a year later.
00:33Israelis said relocating manufacturing to the U.S. could take four to seven years and is
00:38not economically viable because production costs are higher than in India.
00:42Nomura also said the tariffs are unlikely to shift manufacturing, but could allow generic
00:46drug makers to raise prices and improve profits.
00:49For all things money, visit Benzinga.com.
Comments